Drug Patent Watch

FEBRUARY 12, 2025

Accelerating Generic Drug Development: Strategies for Success As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of generic drug development. The generic drug development process involves several stages, from patent research to regulatory approvals.

Drug Development 66

Drug Development Drugs Compliance Regulations 66

Drug Patent Watch

DECEMBER 30, 2024

The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA) The PMDA is the primary regulatory authority responsible for overseeing the drug approval process in Japan.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Drug Patent Watch

JANUARY 14, 2025

Benefits of the Portfolio-Centric Approach Risk mitigation Increased profitability Broader market presence Therapeutic Area Dominance Some manufacturers are choosing to become the Gordon Ramsay of specific therapeutic areas. Case Study 3: Modeling the Future of Generic Drugs Who says you need a crystal ball to predict the future?

Drug Development 74

Drug Development Drugs FDA Production 74

Drug Patent Watch

MARCH 4, 2025

The Unseen Heroes of Generic Drug Development: Pharmacovigilance As a generic drug developer, you're no stranger to the challenges of bringing affordable medications to market. But have you ever stopped to think about the unsung heroes of generic drug development?

Drug Development 52

Drug Development Drugs Government Production 52

PPD

DECEMBER 16, 2024

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.

Drug Development 52

Drug Development Clinical Trials Compliance Trials 52

PPD

MARCH 11, 2025

Developing treatments for individuals living with rare diseases is critical, but orphan drug development is laden with unique obstacles that necessitate innovative, multifaceted approaches. Data from these studies can accelerate research timelines and improve trial planning throughout the product life cycle.

Drug Development 52

Drug Development Clinical Trials Disease Trials 52

Drug Patent Watch

MARCH 18, 2025

In emerging markets, the struggle to provide quality healthcare is often hindered by the high cost of branded medications. This is where generic drug development comes in a game-changer for millions of people around the world. Share your thoughts in the comments below! Read the full article here: [link]

Drug Development 52

Drug Development Marketing Pharmaceutical Companies Drugs 52

Drug Patent Watch

APRIL 24, 2025

"Warning: Are You About to Fall into the Generic Drug Development Trap? As a seasoned pharma professional, I've seen it time and time again: promising generic drug candidates that fail to deliver due to avoidable pitfalls. Don't let this happen to you. " #GenericDrugs #Pharma #RegulatoryCompliance

Drug Development 68

Drug Development Drugs Production Marketing 68

Drug Patent Watch

JULY 25, 2024

Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate the market. Here are some key strategies and insights from industry…

Drug Development 105

Drug Development Drugs Marketing 105

Drug Target Review

DECEMBER 20, 2024

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

Perficient: Drug Development

MARCH 6, 2024

In December 2022, the Department of Health and Human Services released a bulletin announcing additional compliance requirements for healthcare marketers when it comes to third-party trackers. The guidance lays forth expectations for how healthcare organizations collect data on activities that take place on their website and mobile apps.

Marketing 122

Marketing Regulations Compliance Science 122

BioPharma Drive: Drug Pricing

SEPTEMBER 30, 2024

Clinical services organizations can help pharma with global drug development and clinical trial challenges.

Clinical Trials 130

Clinical Trials Marketing Drug Development Trials 130

BioPharma Drive: Drug Pricing

NOVEMBER 4, 2024

As novel therapeutics become more complex — and costly — to bring to market, drug developers are looking to unified clinical development platforms to streamline operations.

Production 204

Production Clinical Development Drug Development Marketing 204

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. This exclusivity is a result of the patent protection granted to the drug's developer. Read the full article here: [link]

Marketing 53

Marketing Drugs Production Pharmaceuticals 53

PPD

SEPTEMBER 25, 2023

As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. The adoption of new innovations, strategies and technologies offers opportunities to address persistent challenges and develop suitable approaches for the future.

Drug Development 104

Drug Development Clinical Trials Drugs Trials 104

DrugBank

OCTOBER 17, 2024

Data science has emerged as an innovative tool in the biopharmaceutical industry, leveraging the power of machine learning and artificial intelligence to drive innovation and efficiency across the entire drug development lifecycle. This was seen in the case of the BRAF V600E mutation test for melanoma patients receiving vemurafenib.

Drug Development 98

Drug Development Metabolic Stability Clinical Trials Drugs 98

Drug Patent Watch

MARCH 10, 2025

The Future of Generic Drugs: How Technology is Revolutionizing the Industry As we continue to navigate the ever-changing landscape of healthcare, one thing is clear: technology is playing an increasingly important role in shaping the future of generic drug development. Will we see a surge in new treatments and medications?

Drug Development 52

Drug Development Pharmaceutical Companies Drugs Treatment 52

Broad Institute

DECEMBER 18, 2023

Brain disorders are difficult to study and many drug candidates have failed in clinical trials, causing pharmaceutical companies to reduce their investments or even exit the field entirely. So the need and the markets are there. What do you think it will take for industry to re-engage in this space?

Drug Development 130

Drug Development Clinical Trials Drugs Disease 130

Fierce BioTech

OCTOBER 21, 2024

Carl Sailer is Vice President of Full Service Solutions at Syneos Health®, a leading fully integrated biopharmaceutical solutions organization providing clinical development and commercialization s | In this conversation with Fierce Biotech, we explore the ever-evolving biotech landscape.

Marketing 98

Marketing Clinical Development Drug Development Drugs 98

Drug Patent Watch

SEPTEMBER 10, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the passage of the Hatch-Waxman Act in 1984 and subsequent legislation. Today, the market is more competitive than ever, with generic drugs accounting for over 90% of all prescriptions in the United States.

Drug Development 104

Drug Development Drugs Marketing 104

Perficient: Drug Development

MAY 14, 2024

Many healthcare marketers grapple with accessing timely, reliable data to power meaningful campaigns. Enter Perficient’s Patient 360, leveraging Salesforce Data Cloud, Health Cloud and Marketing Cloud – a solution tailored to meet the demands of modern healthcare marketing.

Marketing 111

Marketing Hospitals Science 111

BioPharma Drive: Drug Pricing

JULY 17, 2023

With this highly marketable dosage form, scientists can effectively formulate poorly soluble drugs and supplements, while reducing development time and costs.

Drug Development 130

Drug Development Drugs Marketing 130

Drug Patent Watch

MARCH 26, 2025

The Unseen Hurdles of Generic Drug Development: Lessons Learned As the pharmaceutical industry continues to evolve, one thing remains constant: the pursuit of affordable, high-quality medications for patients worldwide. However, the journey to bringing a generic drug to market is often fraught with challenges.

Compliance 52

Compliance Drug Development Drugs Clinical Trials 52

Perficient: Drug Development

SEPTEMBER 17, 2024

This year, I’m particularly excited about how far we’ve advanced with Optimizely One in collaboration with Perficient, which is described as an operating system for marketing teams. Many organizations are shifting away from piecing together various products to build their marketing technology systems. Will you be at Opticon 2024?

Marketing 109

Marketing Production Government 109

BioPharma Drive: Drug Pricing

FEBRUARY 10, 2025

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.

Drug Development 184

Drug Development Marketing Drugs 184

PPD

SEPTEMBER 6, 2023

Mixing of service models — a strategy that drug developers are leveraging now more than ever — can bring life-changing therapies to market faster. Growth of the FSP market is steadily increasing. In 2018, market utilization of FSO models was at 72%, with usage of FSP models lagging at 28%.

Drug Development 98

Drug Development Clinical Trials Drugs Clinical Research 98

Chemical Biology and Drug Design

MAY 10, 2025

ABSTRACT Carprofen, a nonsteroidal anti-inflammatory drug (NSAID) derived from propanoic acid, is known for its analgesic and antipyretic properties. With ongoing research pushing the boundaries of its potential, carprofen remains a promising candidate for innovation in drug development and treatment strategies.

Small Molecule 100

Small Molecule Drug Development Science Therapies 100

Perficient: Drug Development

APRIL 16, 2024

IDC Market Glance: Payer, 2Q24 Perficient is excited to be included in the IDC Market Glance: Payer, 2Q24 (doc #US51961724, April 2024) report. According to IDC, this report “provides a glance at the current makeup of the payer IT landscape, illustrates the vendor landscape, and depicts the segments and structure of the market.”

Marketing 107

Marketing Government 107

Drug Patent Watch

DECEMBER 9, 2024

This approach has led to the discovery of numerous potential drug candidates. From Lab to Market: The Long Road of Drug Development Once a promising compound is identified, it enters the long and costly process of drug development. Q: How long does a drug patent last?

Drugs 96

Drugs Drug Development Pharmaceuticals Production 96

Perficient: Drug Development

MAY 22, 2025

Overview Opal is Optimizelys AI assistant designed to accelerate and enhance the entire marketing workflow. Content Generation Opal uses AI to generate a wide range of SEO-optimized content such as headlines, product descriptions, and marketing texts for digital channels including web, email, and social media.

Marketing 52

Marketing Compliance Production Government 52

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.

Licensing 91

Licensing Licensing Drugs Biosimilars 91

PPD

JANUARY 15, 2025

Accelerate customer speed to market With a modern and integrated user experience, AI solutions put the right data and insights into the right hands in real time. As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster.

Clinical Trials 95

Clinical Trials Trials Clinical Research Drug Development 95

Perficient: Drug Development

OCTOBER 9, 2024

IDC Market Glance: Digital Business Professional Services, 3Q24 Perficient is thrilled to be included in the Technology Transformation Dominant consultancy category in the latest IDC Market Glance: Digital Business Professional Services report (doc #US51480824, September 2024).

Marketing 105

Marketing 105

Perficient: Drug Development

APRIL 7, 2025

Migrating from Eloqua to Salesforce Marketing Cloud: A Step-by-Step Guide Transitioning from Oracle Eloqua to Salesforce Marketing Cloud (SFMC) is a significant move that can unlock new capabilities, improve personalization, and better align your marketing stack with your broader Salesforce ecosystem.

Marketing 52

Marketing Packaging 52

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. Cavlan explains that “they are brilliant at developing and bringing new drugs to market.”

Drug Development 98

Drug Development Drugs Clinical Development Pharmaceutical Companies 98

FDA Law Blog: Biosimilars

APRIL 8, 2025

Leading FDAs implementationof the Drug Competition Action Plan (DCAP). The DCAP was an initiative launched in 2017 to remove barriers to generic drug development, approval, and market entry (see our previous post here ). facilitating the twice annual updates to the Off-Patent, Off-Exclusivity List ).

FDA 144

FDA Drugs Production Drug Development 144

Drug Patent Watch

DECEMBER 18, 2024

Drug patent prosecution is a complex and critical process that can make or break the success of a new medication. As a business professional in the pharmaceutical industry, understanding and implementing effective strategies for drug patent prosecution can be the difference between market domination and missed opportunities.

Pharmaceuticals 97

Pharmaceuticals Drugs Drug Development Marketing 97